"","KIT","TP53","CSF2RB","IRF5","FLT1","NTRK1","APC","DGKI","PRKAG2","USP9X","PRKAB2","PYGL","TTN","MYL1","LNX1","XBP1"
"Cytosolic sulfonation of small molecules",0.83307794610157,0.830195695428328,0,0.833402528951576,0,0,0,0.88179978555044,0,0.880669122488013,0,0.882254310177675,0,0,0,0
"Synthesis of Prostaglandins (PG) and Thromboxanes (TX)",0.806221337007365,0.855073650679276,0.804905341424121,0.806591218554347,0,0,0,0,0.805635890453214,0,0.805569689273056,0,0,0,0.802539270616625,0
"APAP ADME",0.777324501608359,0.818983099500643,0,0.777653970387751,0.778978626547683,0,0,0,0,0.825724238099195,0,0,0.781740602582667,0.780881528709241,0,0
"RA biosynthesis pathway",0,0,0,0,0,0,0,0.880942239679449,0,0,0,0,0,0,0,0
"O-linked glycosylation of mucins",0.905067468948885,0.902614463639468,0.904311237391527,0,0.905310820132895,0.904717556049778,0.927700665072389,0,0.904724380145311,0,0.904695747157891,0,0,0,0,0
"Termination of O-glycan biosynthesis",0.840348090166839,0.837624912714281,0.840877508564925,0,0.84081457725765,0.841656392832945,0.885508465795096,0,0,0,0,0,0,0,0,0
"Phase II - Conjugation of compounds",0.743974441099764,0.759424011443549,0,0.744102463013859,0,0,0.72733490148935,0.763496048309374,0.763003240105432,0.763050092371019,0.744200541550827,0.763455322541244,0,0,0.722968972929372,0.74358754416873
"Initial triggering of complement",0.818540904732385,0.815699965238339,0.775411041286614,0.764524214759827,0.819027564754669,0.776223607899279,0,0,0,0,0,0,0.821512562109447,0.820678358530862,0,0.769035220424281
"Classical antibody-mediated complement activation",0.611841574181056,0,0.613220963311103,0,0,0.615250330814682,0,0,0,0,0,0,0,0,0,0
